Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients

S. Soverini, C. de Benedittis, C. Papayannidis, K. Machova Polakova, C. Venturi, D. Russo, P. Bresciani, A. Iurlo, M. Mancini, A. Vitale, S. Chiaretti, R. Foà, E. Abruzzese, F. Sorà, A. Kohlmann, T. Haferlach, M. Baccarani, M. Cavo, G. Martinelli

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1615-1619
Number of pages5
JournalLeukemia
Volume30
Issue number7
DOIs
Publication statusPublished - 2016

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

Soverini, S., de Benedittis, C., Papayannidis, C., Polakova, K. M., Venturi, C., Russo, D., Bresciani, P., Iurlo, A., Mancini, M., Vitale, A., Chiaretti, S., Foà, R., Abruzzese, E., Sorà, F., Kohlmann, A., Haferlach, T., Baccarani, M., Cavo, M., & Martinelli, G. (2016). Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients. Leukemia, 30(7), 1615-1619. https://doi.org/10.1038/leu.2016.17